Cargando…
Mortality is not associated with paclitaxel-coated devices usage in peripheral arterial disease of lower extremities
A recent meta-analysis addressed increased risk of death following revascularization with paclitaxel-coated devices in femopopliteal artery. We evaluated differences in all-cause mortality and amputation free survival between peripheral arterial disease (PAD) patients who were treated with paclitaxe...
Autores principales: | Ko, Dai Sik, Bae, Gi Hwan, Choi, Sang Tae, Jung, Jaehun, Kang, Jin Mo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440584/ https://www.ncbi.nlm.nih.gov/pubmed/34521940 http://dx.doi.org/10.1038/s41598-021-97675-9 |
Ejemplares similares
-
Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
por: Swaminathan, Rajesh V., et al.
Publicado: (2019) -
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019) -
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel‐Coated Devices: Insights From the Veterans Health Administration
por: Gutierrez, Jorge Antonio, et al.
Publicado: (2021) -
A pilot study of a novel paclitaxel-coated angioplasty catheter for lower extremity peripheral artery disease: a pilot study
por: Şahin, Serpil, et al.
Publicado: (2023) -
Mortality following operations for lower extremity peripheral arterial disease
por: Collins, Tracie C, et al.
Publicado: (2010)